Dny Remedies India Private Limited - Company Profile

It is a pharma private limited company based in Navi Mumbai, Maharashtra, India, established in 2016.

2016 Navi Mumbai, Maharashtra, India Active

Last Updated: February 23, 2026

About Dny Remedies India Private Limited

Dny Remedies India Private Limited, a active private limited company, was established on 29 April 2016 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100MH2016PTC280385. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Suresh Dnyanobarao Kute (Director), Archana Suresh Kute (Director). Its latest AGM occurred on 29 September 2022, with the balance sheet filed on 31 March 2022. It is based at Office No 1903A, Haware Infotech Park Plot No 39/3, Sector No 30A, Vashi, Navi Mumbai, Maharashtra, 400706.

Company Details

CIN/LLPIN
U24100MH2016PTC280385
Registration Number
280385
Incorporation Date
29 April 2016
Authorized Capital
₹0.10 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Mumbai I
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.10 M as on 23-02-2026
Paid Up Capital ₹ 0.10 M as on 23-02-2026
Company Age 9 Year, 10 Months
Last Filing with ROC 31 Mar 2022
Revenue Growth **** % (FY 2021)
Profit Growth **** 57.52% (FY 2021)
Ebitda **** -5.00% (FY 2021)
Net Worth -5.41% (FY 2021)
Total Assets **** 143.26% (FY 2021)

Comprehensive Company Insights

Explore comprehensive insights into Dny Remedies India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Dny Remedies India Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Suresh Dnyanobarao Kute	Director	29 Apr 2016	Current
Archana Suresh Kute	Director	29 Apr 2016	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dny Remedies India.

Dny Remedies India Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 57.52% increase in profit. The company's net worth dipped by a decrease of 5.41%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

143.26%

*******

Profit or Loss

*******

57.52%

*******

Net Worth

*******

-5.41%

*******

EBITDA

*******

-5.00%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dny Remedies India?

In 2020, Dny Remedies India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dny Remedies India?

Unlock and access historical data on people associated with Dny Remedies India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Dny Remedies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dny Remedies India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dny Remedies India

Recent Activity within the Organization

Annual General Meeting

The activity Dny Remedies India Private Limited last Annual general meeting of members was held on 29 Sep 2022 as per latest MCA records. was completed.
29 Sep 2022
Balance Sheet

Progress on Dny Remedies India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai I. was documented.
31 Mar 2022
Director Appointment

Suresh Dnyanobarao Kute was appointed as a Director was appointed as a Director on 29 Apr 2016 & has been associated with this company since 9 years 10 months . was recorded as a recent event.
29 Apr 2016
Director Appointment

Progress on Archana Suresh Kute was appointed as a Director was appointed as a Director on 29 Apr 2016 & has been associated with this company since 9 years 10 months . was documented.
29 Apr 2016
Company Incorporation

Dny Remedies India Private Limited was registered on 29 Apr 2016 with Roc Mumbai I & aged 9 years 10 months as per MCA records. was recorded as a recent event.
29 Apr 2016

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Dny Remedies India Private Limited?

The CIN of Dny Remedies India Private Limited is U24100MH2016PTC280385.

Where is Dny Remedies India Private Limited headquartered?

Dny Remedies India Private Limited is headquartered at Office No 1903A, Haware Infotech Park Plot No 39/3, Sector No 30A, Vashi, Navi Mumbai, Maharashtra, 400706.

When was Dny Remedies India Private Limited incorporated?

Dny Remedies India Private Limited was incorporated on 29 April 2016.

Who are the current directors of Dny Remedies India Private Limited?

The current directors of Dny Remedies India Private Limited are

What is the primary industry of Dny Remedies India Private Limited?

The primary industry of Dny Remedies India Private Limited is Manufacturing.

Is Dny Remedies India Private Limited a listed company?

Dny Remedies India Private Limited is unlisted.

What is the capital structure of Dny Remedies India Private Limited?

The authorized capital of Dny Remedies India Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Dny Remedies India Private Limited?

The compliance status of Dny Remedies India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available